BiotechTube
Home/Okogen/Joshua H. Moriarty
JH

Joshua H. Moriarty

Chief Executive Officer & Director

Okogen

Therapeutic Areas

OphthalmologyInfectious Disease

Okogen Pipeline

DrugIndicationPhase
OKG-0303Acute Infectious Conjunctivitis (Bacterial and Viral)Phase 2b

Leadership Team at Okogen

DA
David A. Hollander, MD, MBA
Chief Medical Officer
BA
Bradford A. Conlan
Executive Chairman
BM
Brian M Strem, PhD
Non-Executive Director, Co-founder
View full Okogen profile